SGRT for Lung

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
LungSGRT - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing two different radiation therapy techniques for tumors in the lungs. One technique uses a guidance system to help target the radiation, and the other doesn't.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12 months

12 months
Incidence of SBRT and fiducial-related pulmonary toxicities as assessed by NCI CTCAE v.5.0

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Group 2
1 of 3
Group 3
1 of 3
Group 1
1 of 3

Experimental Treatment

45 Total Participants · 3 Treatment Groups

Primary Treatment: SGRT · No Placebo Group · N/A

Group 2
Device
Experimental Group · 1 Intervention: SGRT · Intervention Types: Device
Group 3
Device
Experimental Group · 1 Intervention: SGRT · Intervention Types: Device
Group 1
Device
Experimental Group · 1 Intervention: SGRT · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,122 Previous Clinical Trials
1,126,997 Total Patients Enrolled
2 Trials studying Lung
131 Patients Enrolled for Lung
Atrium HealthLead Sponsor
121 Previous Clinical Trials
35,381 Total Patients Enrolled
1 Trials studying Lung
61 Patients Enrolled for Lung
John Heinzerling, MDPrincipal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are able to understand and comply with study procedures for the entire length of the study.
Women of child-bearing potential and non-sterilized men who are sexually active with a woman of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study treatment
You are eligible for release of your personal health information.\n